Business Context and Reporting Period
Company: Healthcare Trust of America, Inc. (HTA) and Healthcare Trust of America Holdings, LP (Operating Partnership).
Filing Type: Form 8-K (Current Report).
Reporting Date: November 21, 2014 (Event Date: November 19, 2014).
Context: The registrants entered into a new material definitive credit agreement to refinance and expand their unsecured debt facilities.
Key Financial Metrics and Debt Structure
This filing details the creation of a new unsecured credit facility rather than reporting operational financial results (revenue, profit, or cash flow). Key debt metrics include:
- Total New Facility Size: $1.1 billion aggregate maximum principal amount.
- Revolving Credit Facility (Revolver): $800 million maximum principal. Includes capacity for up to $65 million in letters of credit and $50 million in swingline loans.
- Term Loan Facility: $300 million maximum principal.
- Expansion Option: The facility may be increased by up to $450 million, bringing the total potential principal to $1.55 billion.
- Interest Rates:
- Variable rate based on Adjusted LIBO Rate plus a margin of 0.875% to 1.80% (or Prime/Federal Funds rate plus 0.00% to 0.80%).
- Margins are tied to the Operating Partnership's credit rating.
- Facility Fee: 0.125% to 0.30% per annum on Revolver commitments.
- Maturities: Revolver matures in January 2020; Term Loan matures in January 2019 (extendable by one year).
Material Changes Versus Prior Period
The new Credit Agreement amends and restates the previous credit agreement originally entered into on March 29, 2012, and subsequently amended in 2013 and 2014.
- Refinancing: Approximately $200 million of principal and interest was outstanding under the prior facility at the time of closing the new agreement.
- Capacity Increase: The new facility significantly increases available liquidity compared to the prior outstanding balance.
- Covenant Alignment: An existing $155 million unsecured term loan was amended to align its covenants with the new Credit Agreement.
Guidance, Risks, and Management Commentary
Use of Proceeds: Funds may be used for working capital, general corporate purposes, acquisitions, and repayment of debt.
Covenants and Restrictions: The agreement includes standard financial covenants, including:
- Maximum ratio of total indebtedness to total asset value.
- Maximum ratio of secured indebtedness to total asset value.
- Minimum ratio of EBITDA to fixed charges.
- Maximum ratio of unsecured indebtedness to unencumbered asset value.
- Minimum ratio of unencumbered net operating income to unsecured interest expense.
Distribution Restrictions: The company is restricted from making distributions to stockholders if in default under the Credit Agreement, except as necessary to maintain REIT status.
Events of Default: Includes non-payment, covenant breaches, bankruptcy, or insolvency.
Management Commentary: The filing references a press release issued on November 20, 2014, announcing the $1.1 billion facility, but does not provide additional forward-looking guidance or specific outlook metrics within this text.
Investor Verification Checklist
- Verify the specific credit rating of the Operating Partnership to determine the applicable interest rate margin and facility fee.
- Review the full text of the Credit Agreement (Exhibit 10.1) for detailed covenant calculations and definitions of "Total Asset Value" and "EBITDA."
- Confirm the status of the $155 million term loan amendment to ensure full alignment with the new facility terms.
- Monitor the company's leverage ratios to ensure compliance with the new maximum indebtedness-to-asset-value covenants.
- Check for any subsequent drawdowns on the $800 million Revolver or $300 million Term Loan.